HealthQuad secures Rs 550 Cr first close for third healthcare fund

HealthQuad, the healthcare-focused investment platform backed by Quadria Group, has secured first-close commitments of Rs 550 crore for its third fund, HealthQuad Fund III, crossing one-third of its target corpus of Rs 1,700 crore.

The commitments come from a mix of existing limited partners from earlier funds as well as new investors, including domestic and international fund-of-funds, institutions, and family offices.

HealthQuad is one of India’s best-known early-growth healthcare investors, while Quadria Group is among Asia’s largest healthcare-focused investment platforms, managing investments across South and Southeast Asia.

The new fund is expected to back technology-enabled healthcare businesses that have already achieved commercial traction and are positioned for large-scale growth.

The fund has already made its first commitment to Lifesigns, an artificial intelligence-powered remote patient monitoring company.

HealthQuad said it is also evaluating additional proprietary opportunities as it begins constructing the Fund III portfolio.

Founded in 2016, HealthQuad was created to support founders building scalable healthcare businesses using technology, innovative products and new delivery models. Its earlier funds invested in companies such as Qure.ai, Redcliffe Labs, Wysa, Cureskin, Medikabazaar and Ekincare, several of which have emerged as prominent names in India’s healthcare technology landscape.

Fund III will focus on HealthTech, MedTech, BioPharma Tech, and novel healthcare delivery models. These segments are expanding at annual rates ranging from 16% to 40%, and could account for more than 40% of India’s projected $600 billion healthcare market by 2030, according to the firm.

Rahul Agarwal, Partner and Investment Committee member at HealthQuad, said the healthcare sector is experiencing a major transformation driven by technology and AI. He noted that “the next decade will be defined by companies that leverage emerging technologies and AI” to make healthcare more accessible, affordable and focused on outcomes.

The investment thesis is closely linked to India’s healthcare challenges. HealthQuad estimates that bridging healthcare access gaps will require more than double the current bed capacity, over seven times the existing clinical workforce and around $500 billion of investment. The firm believes technology-led innovation can help improve access, affordability and quality of care.

The broader backdrop is favourable for healthcare investors. India’s healthtech sector continues to benefit from growing digital adoption, increasing use of AI tools by clinicians and government-led initiatives such as the Ayushman Bharat Digital Mission, which seeks to create a connected digital health ecosystem.

Meanwhile, there has been rising demand for preventive care, digital diagnostics and continuous patient monitoring.

Recent developments highlight sustained investor interest in healthcare and technology. Apollo Hospitals is progressing plans for a separate healthtech business focused on medical technology manufacturing, while healthcare AI companies such as Qure.ai are pursuing global expansion and preparing for potential public market listings.

Sunil Thakur, Co-founder and Investment Committee member at HealthQuad and Partner at Quadria Capital, said the firm was built on the belief that healthcare requires specialist investors capable of supporting founders through long growth cycles. He added Fund III reflects HealthQuad’s conviction that a new generation of entrepreneurs is creating world-class healthcare businesses from India and Asia.

With more than $400 million in assets under management across three funds and the backing of Quadria’s wider healthcare network, HealthQuad is positioning Fund III to capture the next wave of innovation in Indian healthcare, particularly where technology can help address long-standing gaps in access and delivery.